Cargando…
Newborn screening for Fabry disease in the north-west of Spain
Fabry disease is an X-linked lysosomal storage disorder caused by the impairment of α-galactosidase A. Enzyme replacement therapy is available to treat patients, who often experience delayed diagnosis. A newborn screening for Fabry disease was performed to study the prevalence of the pathology and t...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511307/ https://www.ncbi.nlm.nih.gov/pubmed/28646478 http://dx.doi.org/10.1007/s00431-017-2950-8 |
_version_ | 1783250317261930496 |
---|---|
author | Colon, Cristobal Ortolano, Saida Melcon-Crespo, Cristina Alvarez, Jose V. Lopez-Suarez, Olalla E. Couce, Maria L. Fernández-Lorenzo, José R. |
author_facet | Colon, Cristobal Ortolano, Saida Melcon-Crespo, Cristina Alvarez, Jose V. Lopez-Suarez, Olalla E. Couce, Maria L. Fernández-Lorenzo, José R. |
author_sort | Colon, Cristobal |
collection | PubMed |
description | Fabry disease is an X-linked lysosomal storage disorder caused by the impairment of α-galactosidase A. Enzyme replacement therapy is available to treat patients, who often experience delayed diagnosis. A newborn screening for Fabry disease was performed to study the prevalence of the pathology and to evaluate the possibility to implement the test in systematic screenings. We collected 14,600 dried blood spot samples (7575 males and 7025 females) and carried out a diagnostic study by fluorometric measurement of α-galactosidase A enzymatic activity and GLA gene sequencing. We detected one patient with a mutation in GLA associated with classical Fabry Disease (M290I), ten subjects carrying genetic variants of uncertain diagnosis (S126G, R118C, A143T), and a girl with the non-characterized variant F18Y, which was not previously described. Additional 25 samples presented nucleotide substitutions described as polymorphisms (D313Y, rs2071225, and rs2071397). The estimated prevalence for Fabry disease in north-western Spanish males is of 0.013%. Conclusion: These results confirm that the prevalence of Fabry disease is underestimated and systematic screening is feasible; however, further characterization of variants of uncertain clinical significance is necessary to establish protocols of patients’ management. |
format | Online Article Text |
id | pubmed-5511307 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-55113072017-07-31 Newborn screening for Fabry disease in the north-west of Spain Colon, Cristobal Ortolano, Saida Melcon-Crespo, Cristina Alvarez, Jose V. Lopez-Suarez, Olalla E. Couce, Maria L. Fernández-Lorenzo, José R. Eur J Pediatr Original Article Fabry disease is an X-linked lysosomal storage disorder caused by the impairment of α-galactosidase A. Enzyme replacement therapy is available to treat patients, who often experience delayed diagnosis. A newborn screening for Fabry disease was performed to study the prevalence of the pathology and to evaluate the possibility to implement the test in systematic screenings. We collected 14,600 dried blood spot samples (7575 males and 7025 females) and carried out a diagnostic study by fluorometric measurement of α-galactosidase A enzymatic activity and GLA gene sequencing. We detected one patient with a mutation in GLA associated with classical Fabry Disease (M290I), ten subjects carrying genetic variants of uncertain diagnosis (S126G, R118C, A143T), and a girl with the non-characterized variant F18Y, which was not previously described. Additional 25 samples presented nucleotide substitutions described as polymorphisms (D313Y, rs2071225, and rs2071397). The estimated prevalence for Fabry disease in north-western Spanish males is of 0.013%. Conclusion: These results confirm that the prevalence of Fabry disease is underestimated and systematic screening is feasible; however, further characterization of variants of uncertain clinical significance is necessary to establish protocols of patients’ management. Springer Berlin Heidelberg 2017-06-23 2017 /pmc/articles/PMC5511307/ /pubmed/28646478 http://dx.doi.org/10.1007/s00431-017-2950-8 Text en © The Author(s) 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. |
spellingShingle | Original Article Colon, Cristobal Ortolano, Saida Melcon-Crespo, Cristina Alvarez, Jose V. Lopez-Suarez, Olalla E. Couce, Maria L. Fernández-Lorenzo, José R. Newborn screening for Fabry disease in the north-west of Spain |
title | Newborn screening for Fabry disease in the north-west of Spain |
title_full | Newborn screening for Fabry disease in the north-west of Spain |
title_fullStr | Newborn screening for Fabry disease in the north-west of Spain |
title_full_unstemmed | Newborn screening for Fabry disease in the north-west of Spain |
title_short | Newborn screening for Fabry disease in the north-west of Spain |
title_sort | newborn screening for fabry disease in the north-west of spain |
topic | Original Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5511307/ https://www.ncbi.nlm.nih.gov/pubmed/28646478 http://dx.doi.org/10.1007/s00431-017-2950-8 |
work_keys_str_mv | AT coloncristobal newbornscreeningforfabrydiseaseinthenorthwestofspain AT ortolanosaida newbornscreeningforfabrydiseaseinthenorthwestofspain AT melconcrespocristina newbornscreeningforfabrydiseaseinthenorthwestofspain AT alvarezjosev newbornscreeningforfabrydiseaseinthenorthwestofspain AT lopezsuarezolallae newbornscreeningforfabrydiseaseinthenorthwestofspain AT coucemarial newbornscreeningforfabrydiseaseinthenorthwestofspain AT fernandezlorenzojoser newbornscreeningforfabrydiseaseinthenorthwestofspain |